RELMADA THERAPEUTICS, INC. Notes Payable, Current
RELMADA THERAPEUTICS, INC. (RLMD) had Notes Payable, Current of $110.25 thousand as of 2019-12-31, per its 10-K filed 2021-03-24.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Notes and Loans Payable, Current › Notes Payable, Current
us-gaap:NotesPayableCurrent · last filed 2021-03-24
- 2019-12-31: Notes Payable, Current $110.25K.
- 2019-09-30: Notes Payable, Current $255.93K.
- 2019-06-30: Notes Payable, Current $364.20K.
- 2019-03-31: Notes Payable, Current $28.77K.
| Period end | Notes Payable, Current |
|---|---|
| 2019-12-31 | $110.25K 10-K · filed 2021-03-24 |
| 2019-09-30 | $255.93K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $364.20K 10-K · filed 2021-03-24 |
| 2019-03-31 | $28.77K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $114.74K 10-Q · filed 2019-02-13 |
| 2018-09-30 | $200.20K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $285.17K 10-KT · filed 2020-03-26 |
| 2018-03-31 | $27.88K 10-Q · filed 2018-05-14 |
| 2017-12-31 | $111.23K 10-Q · filed 2018-02-12 |
| 2017-09-30 | $194.16K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $276.67K 10-K · filed 2018-09-28 |
| 2017-03-31 | $27.58K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $110.03K 10-Q · filed 2017-02-10 |
| 2016-09-30 | $164.44K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $273.67K 10-K · filed 2017-09-28 |
| 2015-12-31 | $88.53K 10-Q · filed 2016-02-05 |
| 2015-09-30 | $176.45K 10-Q · filed 2015-11-06 |
| 2015-06-30 | $263.75K 10-K · filed 2016-09-09 |
| 2014-12-31 | $38.09K 10-Q · filed 2015-02-13 |
| 2014-06-30 | $58.36K 10-K · filed 2015-09-11 |
| 2014-03-31 | $844.29K 8-K · filed 2014-05-27 |
| 2013-12-31 | $758.95K 10-KT · filed 2014-09-09 |
| 2012-12-31 | $153.68K 8-K · filed 2014-05-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |